Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Publication of AR106533A1publicationCriticalpatent/AR106533A1/en
Terapias de combinación para enfermedades malignas heme con anticuerpos anti-CD38 e inhibidores de survivina.Combination therapies for malignant diseases heme with anti-CD38 antibodies and survivin inhibitors.
ARP160103317A2016-04-062016-10-31
COMBINATION OF THERAPIES FOR HEMO DISEASES WITH ANTI-CD38 ANTIBODIES AND SURVIVINE INHIBITORS
AR106533A1
(en)